Chengdu D-innovation Pharmaceutical Co., Ltd.

Business Type:Manufacturer

Main Products:Elagolix Sodium,Eltrombopag Olamine,Nintedanib,Nintedanib Ethanesulfonate,Ulipristal Acetate,Isavuconazonium Sulfate,Lumateperone Tosilate,Lenvatinib Mesylate,Crisaborole,Mirogabalin Besylate

Country/Region:China

Annual Revenue:3000000 USD

Ddu Verified

HOT Rank

6/10
Company Information

Chengdu D-innovation Pharmaceutical Co., Ltd, founded in 2007, is a professional hi-tech enterprise engaging in the research, development and manufacturing of innovative intermediates & APIs. Currently we have R&D center, world class Research Labs, Scale-up Labs and an analytical center for quality study and test. The center is operated by a dynamic team and the core R&D team is consist of master and Ph D graduates, and offering CRO/CDMO and technical consultant services to the customers. We also have a factory in Western Medical Valley of Meishan City, occupied 25000M2 including 8 multifunctional workshops and 2 clean areas meeting the GMP requirements. All our workshops are equipped with multifunctional reactors from 200L to 2000L, and can undertake all kinds of reactions such as nitration reactions, chiral synthesis, coupling reaction and halogenation reactions etc. Reactors are made of enamel or stainless steel and can bear reactions from -80℃-250℃. According to cGMP requirements, we have established the quality management system in the production site, which is operated under ISO9001, ISO 14001, ISO45001 as well as high EHS standards. Until now, we have accepted the domestic and international customers audits from Europe, Japan, India and domestic pharmaceutical companies.

Our goal is to establish long-term collaboration with famous pharmaceutical companies’ home and aboard, and provide products and services with excellent quality, competitive price, responsible attitude and fast delivery. We sincerely expect to establish long-term strategic business relation in near future. 


Email to this supplier
To

Send

Inquiry Cart(0)